In PCa, expression of KRT8, KRT18, and KRT19 by tumor cells disseminated to the bone, is associated with a worse prognosis (49); KRT18 and KRT5 expression correlates with metastases and hormone-escaped prostate carcinomas, respectively (55). Here, KRT18 is linked to posterior cortical atrophy.